Report: The Dynamic Media, Sera and Reagent Market in Biotechnology TOC

INTRODUCTION
- STUDY OBJECTIVES
- REASONS FOR DOING THIS STUDY
- CONTRIBUTIONS TO THE STUDY
- SCOPE OF THE STUDY
- METHODOLOGY
- INFORMATION SOURCES
- ANALYST' S CREDENTIALS
- RELATED BCC PUBLICATIONS
- DISCLAIMER
EXECUTIVE SUMMARY
- Summary Table:
- U.S. SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, THROUGH 2011 ($ MILLIONS)
- Summary Figure:
- U.S. SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, 2004-2011 ($ MILLIONS)
OVERVIEW
- DEFINITIONS
- MAIN TYPES OF CELL CULTURES
  - PRIMARY CULTURES
  - CONTINUOUS CULTURES
  - CULTURE MORPHOLOGY
- CELL CULTURE MEDIA
Table 1 TYPES OF CULTURE MEDIA AND THEIR USES
- BASIC CONSTITUENTS OF MEDIA
  - Inorganic Salts
Table 2 THE ROLES OF DIFFERENT INORGANIC NUTRIENTS
- Buffering Systems
- Energy Source
- Amino acids
- Vitamins
- Proteins and Peptides
- Fatty Acids and Lipids
- Trace Elements
- Antibiotics
- Serum
- STORAGE OF MEDIA
  - Different Types of Media
- SERUM-FREE MEDIUM
- SERUM FREE MEDIUM COMPOSITION/CONSTITUENTS
  - Basal Medium
  - Lipids
  - Buffers
  - Trace Elements
  - Mechanical Stabilizers and Adhesion Factors
    - Use of Supplements in Serum-Free Medium
      - Calcium, a Serum-Free Medium Supplement
      - Primary Functions of Calcium in Cell Culture Systems
- Table 3 CONCENTRATION OF CALCIUM IONS IN DIFFERENT MEDIA
  - Pyridoxal and Pyridoxine, a Serum Free-Medium Supplement
  - Primary Function of Pyridoxal and Pyridoxine in Cell Culture Systems
- Table 4 CONCENTRATION OF VITAMIN B12 IN DIFFERENT MEDIA
  - L-Glutamine, a Serum-Free Medium Supplement
  - Primary Function of Glutamine in Cell Culture Systems
- Table 5 CONCENTRATION OF GLUTAMINE IN DIFFERENT MEDIA
  - Stearic Acid, A Serum-Free Supplement
  - Primary Function of Stearic Acid in Cell Culture Systems
  - Transferrin, a Serum-free Supplement
  - Primary Functions of Transferrin in Cell Culture Systems
  - Zinc, a Serum-free Medium Supplement
  - Primary Functions of Zinc in Cell Culture Systems
  - Table 6 CONCENTRATION OF ZINC IN DIFFERENT MEDIA
  - Insulin, a Serum-free Media Supplement
  - Thrombin, a Serum-free Supplement
- Table 7 SERUM CONTAINING MEDIUM VS SERUM FREE MEDIUM
  - Disadvantage of Using Serum-free Medium
- SIGNIFICANT PROTEIN -FREE AND ANIMAL-ORIGIN FREE PRODUCTS
  - SERUM
- Table 8 LIST OF TYPES OF SERA
  - CONSTITUENTS OF SERUM
    - Protein and Peptides
      - Growth Factors
      - Albumin
      - Transferrin
- Protease Inhibitors
- Amino Acids
- Carbohydrates
- Fatty Acids and Lipids
- Inorganic Salts
- Vitamins and Minerals
- Others
- Infectious Agent
- Table 9 NORMAL RANGE OF CONCENTRATION OF SERUM CONSTITUENTS
- SOURCES OF SERUM
  - Fetal Bovine Serum (FBS)
  - Calf Serum
  - Other Animal Sera
- POTENTIAL PROBLEMS WITH SERUM
- SERUM SELECTION
REAGENTS
- BIOLOGICAL RESPONSE MODIFIERS
  - Growth Factors
  - Cytokines, Lymphokines and Interleukins
- Table 10 LIST OF SELECTED GROWTH FACTORS
- Table 11 LIST OF CYTOKINES
  - Interlukins
- Table 12 LIST OF SELECTED INTERLEUKINS
- Table 13 LIST OF SELECTED LYMPHOKINES AND CYTOKINES
  - Colony-Stimulating Factors
  - Interferons
  - Tumor Necrosis Factor
  - Chemokines
- Table 14 LIST OF SELECTED CHEMOKINES
  - Attachment Factors
- Table 15 LIST OF SELECTED ATTACHMENT FACTORS
  - Serum Replacers or Serum Extenders
- Table 16 SELECTED REAGENTS THAT SUPPLEMENT REDUCED SERUM OR SERUM-FREE MEDIA
  - LIPIDS
  - FACTORS AFFECTING CELL CULTURE
    - Temperature
    - PH
    - Carbon Dioxide (CO2)
    - Humidity
    - Concentration of the Nutrients
- PROBLEMS ARISING DURING CELL CULTURE
- ROLE OF CELL CULTURE
USES OF MEDIA AND SERA AND REAGENTS
- GROWTH FACTORS
  - Neurotrophins
  - Epidermal Growth Factor (EGF)
  - Fibroblast Growth Factor
  - Platelet-Derived Growth Factor (PDGF)
  - Transforming Growth Factor (TGF)
- ANTIBODIES
  - Monoclonal Antibodies
- Table 17 APPLICATIONS OF MONOCLONAL ANTIBODIES
- Table 17 (CONTINUED)
  - Polyclonal Antibody
  - Nanobodies
- STEM CELLS
- Table 18 DIFFERENCES BETWEEN EMBRYONIC STEM CELLS AND ADULT STEM CELLS
  - RECOMBINENT PROTEINS
    - Human Recombinant Proteins
      - Granulocyte Colony-Stimulating Factor (G-CSF)
      - Tissue Plasminogen Activator (PLAT Or Tpa)
      - Interferons (Ifns)
      - Insulin-Like Growth Factor 1 (IGF-1)
- Table 19 A LIST OF HUMAN RECOMBINANT PROTEINS
  - VACCINES
    - Types of Vaccines
    - Innovative Vaccines
      - Innovative Vaccines (Continued)
REGULATORY
- FDA REGULATIONS
- EMEA REGULATIONS
- USDA REGULATIONS
- EDQM REGULATIONS
- Table 20 CERTIFICATE OF SUITABILITY ISSUED BY EDQM FOR ALBUMINS
  - ACTION OF USDA AGAINST BSE
    - NEW DIRECTIVE REGULATIONS REGARDING BSE
- PRODUCTS APPROVED BY FDA IN 2004, 2005 AND 2006
- Table 21 PRODUCTS APPROVED BY FDA, 2004-2006
- Table 21 (CONTINUED)
- Table 21 (CONTINUED)
  - NEW APPROVALS BY EU
    - NEW APPROVALS BY EU (CONTINUED)
INDUSTRY STRUCTURE
- MEDIA
  - MARKET LEADERS OF MEDIA USED IN BIOTECHNOLOGY
- Table 22 MAJOR SUPPLIERS OF MEDIA USED IN BIOTECHNOLOGY
- Table 22 (CONTINUED)
- Table 22 (CONTINUED)
- Table 23 ESTIMATED MARKET SHARE IN 2006 FOR SUPPLIERS AND MANUFACTURERS OF MEDIA (%)
- Figure 1 ESTIMATED MARKET SHARE FOR SUPPLIERS AND MANUFACTURERS OF MEDIA, 2006 (%)
  - SERA
    - MARKET LEADERS OF SERA USED IN BIOTECHNOLOGY
- Table 24 MAJOR SUPPLIERS OF SERA USED IN BIOTECHNOLOGY
- Table 25 ESTIMATED MARKET SHARE IN 2006 FOR SUPPLIERS AND MANUFACTURERS OF SERA (%)
- Figure 2 ESTIMATED MARKET SHARE IN 2006 FOR SUPPLIERS AND MANUFACTURERS OF SERA (%)
  - REAGENTS
    - MARKET LEADERS OF REAGENTS USED IN BIOTECHNOLOGY
- Table 26 MAJOR SUPPLIERS OF REAGENTS USED IN BIOTECHNOLOGY
- Table 26 (CONTINUED)
  - FACTORS INFLUENCING DEMAND AND USE
    - INCREASING USE OF SERUM-FREE MEDIA
    - FDA REGULATIONS
    - COST
    - DEVELOPMENT OF SUCCESSFUL SPECIALTY MEDIA
    - CELL CULTURE PRODUCTS
- FACTORS AFFECTING PRODUCTION OF SERUM
- QUALITY CONTROL
  - THE MATERIALS
    - Media
    - Supplement
    - Vessels
- CULTURE ENVIRONMENT
  - Temperature
  - PH
  - Carbon Dioxide
- CELLS
  - Toxicity
  - Contamination
  - ANTIBIOTICS
- PRICES
  - Table 27 AVERAGE PRICES OF CLASSICAL MEDIA, THROUGH 2006 ($/L)
  - Figure 3 AVERAGE PRICES OF CLASSICAL MEDIA, 2003 AND 2006 ($/L)
  - Table 28 AVERAGE PRICES OF SERA, THROUGH 2006 ($/L)
  - Figure 4 AVERAGE PRICES OF SERA, 2003 AND 2006 ($/L)
TECHNOLOGY
- NEW DEVELOPMENTS
  - NEW DEVELOPMENTS BY VARIOUS COMPANIES
    - Sigma-Adrich
- Table 29 NEW PRODUCTS BY SIGMA-ALDRICH
  - Millipore Corporation
  - Perbio Science
  - Irvine Scientific
- Table 30 NEW PRODUCTS BY IRVINE SCIENTIFIC
  - Invitrogen Corporation
- Table 31 NEW PRODUCTS BY INVITROGEN CORPORATION
  - Fisher Biosciences Unit, (Hyclone)
- Table 32 NEW PRODUCTS BY HYCLONE
  - Athena ES
  - Roche Applied Sciences
- Table 33 NEW PRODUCTS BY ROCHE APPLIED SCIENCES
  - Animal Technologies, Inc.
  - Cellgro (MEDIATECH)
  - Cambrex
  - SAFC
  - Celliance Corporation
- MARKET BY PRODUCT TYPE
  - MEDIA
- Table 34 U.S. MARKET FORECAST FOR SALES OF MEDIA (SERUM FREE AND SERUM REQUIRING), THROUGH 2011 ($ MILLIONS)
- Figure 5 SALES OF MEDIA (SERUM-FREE AND SERUM REQUIRING) IN U.S. ($ MILLIONS)
  - Liquid and Powder media
- Table 35 U.S. MARKET FORECAST FOR SALES OF MEDIA (LIQUID AND POWDER), THROUGH 2011 ($ MILLIONS)
- Figure 6 SALES OF MEDIA (LIQUID AND POWDER) IN U.S. ($ MILLIONS)
  - Classical and Specialty Media
- Table 36 U.S. MARKET FORECAST FOR SALES OF MEDIA (CLASSICAL AND SPECIALTY), THROUGH 2011 ($ MILLIONS)
- Figure 7 SALES OF MEDIA (CLASSICAL AND SPECIALTY) IN U.S. ($ MILLIONS)
  - SERA
- Table 37 U.S. MARKET FORECAST FOR SALES OF SERA, THROUGH 2011 ($ MILLIONS)
- Figure 8 SALES OF SERA IN THE U.S. 2004-2011 ($ MILLIONS)
  - Bovine Sera
- Table 38 U.S. MARKET FORECAST FOR BOVINE SERA, THROUGH 2011 ($ MILLIONS)
- Figure 9 SALES OF BOVINE SERA IN THE U.S., 2004-2011 ($ MILLIONS)
  - REAGENTS
- Table 39 U.S. MARKET FORECAST FOR REAGENTS USED IN BIOTECHNOLOGY, THROUGH 2011 ($ MILLIONS)
- Figure 10 U.S. SALES OF REAGENTS USED IN BIOTECHNOLOGY, 2004-2011 ($ MILLIONS)
- Table 40 U.S. MARKET FORECAST FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2011 ($ MILLIONS)
- Figure 11 SALES OF BIOLOGICAL RESPONSE MODIFIERS IN THE U.S., 2004-2011 ($ MILLIONS)
PATENTS
- PATENTS BY PRODUCT
- Table 41 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2003-2006
- Figure 12 NUMBER OF PATENTS BY YEAR, 2003-2006
- Table 42 PRODUCT-RELATED PATENT BREAKDOWN, 2003-2006
- Figure 13 PRODUCT-RELATED PATENT BREAKDOWN, 2003-2006 (%)
- Table 43 SIGNIFICANT PATENTS FOR MEDIA IN 2006
- Table 44 SIGNIFICANT PATENTS FOR SERA IN 2006
- Table 45 SIGNIFICANT PATENTS FOR REAGENTS IN 2006
- Table 45 (CONTINUED)
- PATENTS BY COMPANY
- Table 46 PATENTS BY COMPANY, 2003-2006
- Table 46 (CONTINUED)
- TRENDS BY EMPHASIS
- Table 47 SHARES OF PATENTS ISSUED BY EMPHASIS, 2003-2006
- Figure 14 SHARES OF PATENTS ISSUED BY EMPHASIS, 2003-2006 (%)
- PATENTS BY COUNTRY
- Table 48 U.S. PATENTS BY COUNTRY AWARDED, 2003-2006
- Table 49 TRENDS OF PATENTS ISSUED BY COUNTRY, 2003-2006
- PATENTS BY ASSIGNEE
- Table 50 SHARES OF U.S. PATENTS BY ASSIGNEE
- Figure 15 NUMBER OF U.S. PATENTS BY ASSIGNEE
- Figure 16 SHARES OF U.S PATENTS BY ASSGINEE (%)
END USERS
- RESEARCH SEGMENT
- Table 51 U.S. EXPENDITURES OF MEDIA, SERA AND REAGENTS IN RESEARCH SEGMENT, THROUGH 2011 ($ MILLIONS)
- Figure 17 U.S. EXPENDITURE OF MEDIA, SERA AND REAGENTS IN RESEARCH SEGMENT, 2004-2011 ($ MILLIONS)
  - PRODUCTION SEGMENT
- Table 52 U.S. MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN PRODUCTION SEGMENT, THROUGH 2011 ($ MILLIONS)
- Figure 18 U.S. SALES OF MEDIA, SERA AND REAGENTS IN PRODUCTION SEGMENT, 2004-2011 ($ MILLIONS)
- CONTRACT SEGMENT
- Table 53 U.S. MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN CONTRACT SEGMENT, THROUGH 2011 ($ MILLIONS)
- Figure 19 U.S. SALES OF MEDIA, SERA AND REAGENTS IN CONTRACT SEGMENT, 2004-2011 ($ MILLIONS)
- OTHER SEGMENT
- Table 54 U.S. MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN OTHER SEGMENTS, THROUGH 2011 ($ MILLIONS)
- Figure 20 U.S. SALES OF MEDIA, SERA AND REAGENTS IN OTHER SEGMENTS ($ MILLIONS)
- NEW AND IMPROVED USES
INTERNATIONAL ASPECTS
- LATIN AMERICA
- Table 55 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN LATIN AMERICA, THROUGH 2011 ($ MILLIONS)
- Figure 21 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN LATIN AMERICA, ($ MILLIONS)
  - EUROPE
- Table 56 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN EUROPE, THROUGH 2011 ($ MILLIONS)
- Figure 22 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN EUROPE, 2004-2011 ($ MILLIONS)
  - ASIA
    - ISRAEL
    - INDIA
    - CHINA
    - JAPAN
- Table 57 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN ASIA, THROUGH 2011 ($ MILLIONS)
- Figure 23 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN ASIA, 2004-2011 ($ MILLIONS)
  - CANADA
- Table 58 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN CANADA, THROUGH 2011 ($ MILLIONS)
- Figure 24 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN CANADA, 2004-2011 ($ MILLIONS)
  - OTHERS
    - RUSSIA
    - CZECH REPUBLIC
    - SOUTH KOREA
- Table 59 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN OTHER COUNTRIES, THROUGH 2011 ($ MILLIONS)
- Figure 25 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN OTHER COUNTRIES, THROUGH 2011 ($ MILLIONS)
- Table 60 GLOBAL MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, THROUGH 2011 ($ MILLIONS)
- Figure 26 GLOBAL MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, 2004-2011 ($ MILLIONS)
- Table 61 GLOBAL MARKET SEGMENT OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, 2006 (%)
- Figure 27 WORLWIDE MARKET SEGMENT OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, 2006 (%)
COMPANY PROFILE
- ADVANCED BIOTECHNOLOGIES, INC. (ABI)
- AMGEN, INC.
- ATLANTA BIOLOGICALS INC.
- ATHENA ES/BIOLOGICAL RESEARCH FACULTY & FACILITY, INC. (BRFF)
- BECTON DICKINSON CO. (BD)
- BIOGEN, IDEC.
- BIOVAIL CORPORATION
- BIORECLAMATION INC.
- CAMBREX CORPORATION
- CELL APPLICATIONS, INC.
- CENTOCOR INC.
- GENENTECH, INC.
- HYCLONE (A SUBSIDIARY OF THERMO FISHER SCIENTIFIC, INC.)
- IRVINE SCIENTIFIC
- INVITROGEN CORPORATION
- MEDIATECH, INC.
- MEDIMMUNE, INC.
- MILLIPORE CORPORATION
- PEPROTECH, INC.
- PDL BIOPHARMA, INC.
- QUALITY BIOLOGICAL INC.
- R&D SYSTEMS INC.
- ROCHE APPLIED SCIENCE
- SIGMA-ALDRICH
- UNITED STATES BIOLOGICAL (U.S. BIOLOGICAL)
GLOSSARY
- GLOSSARY
  - GLOSSARY (CONTINUED)
LIST OF TABLES
- Summary Table:
- U.S. SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, THROUGH 2011 ($ MILLIONS)
- Table 1 TYPES OF CULTURE MEDIA AND THEIR USES
- Table 2 THE ROLES OF DIFFERENT INORGANIC NUTRIENTS
- Table 3 CONCENTRATION OF CALCIUM IONS IN DIFFERENT MEDIA
- Table 4 CONCENTRATION OF VITAMIN B12 IN DIFFERENT MEDIA
- Table 5 CONCENTRATION OF GLUTAMINE IN DIFFERENT MEDIA
- Table 6 CONCENTRATION OF ZINC IN DIFFERENT MEDIA
- Table 7 SERUM CONTAINING MEDIUM VS SERUM FREE MEDIUM
- Table 8 LIST OF TYPES OF SERA
- Table 9 NORMAL RANGE OF CONCENTRATION OF SERUM CONSTITUENTS
- Table 10 LIST OF SELECTED GROWTH FACTORS
- Table 11 LIST OF CYTOKINES
- Table 12 LIST OF SELECTED INTERLEUKINS
- Table 13 LIST OF SELECTED LYMPHOKINES AND CYTOKINES
- Table 14 LIST OF SELECTED CHEMOKINES
- Table 15 LIST OF SELECTED ATTACHMENT FACTORS
- Table 16 SELECTED REAGENTS THAT SUPPLEMENT REDUCED SERUM OR SERUM-FREE MEDIA
- Table 17 APPLICATIONS OF MONOCLONAL ANTIBODIES
- Table 18 DIFFERENCES BETWEEN EMBRYONIC STEM CELLS AND ADULT STEM CELLS
- Table 19 A LIST OF HUMAN RECOMBINANT PROTEINS
- Table 20 CERTIFICATE OF SUITABILITY ISSUED BY EDQM FOR ALBUMINS
- Table 21 PRODUCTS APPROVED BY FDA, 2004-2006
- Table 22 MAJOR SUPPLIERS OF MEDIA USED IN BIOTECHNOLOGY
- Table 23 ESTIMATED MARKET SHARE IN 2006 FOR SUPPLIERS AND MANUFACTURERS OF MEDIA (%)
- Table 24 MAJOR SUPPLIERS OF SERA USED IN BIOTECHNOLOGY
- Table 25 ESTIMATED MARKET SHARE IN 2006 FOR SUPPLIERS AND MANUFACTURERS OF SERA (%)
- Table 26 MAJOR SUPPLIERS OF REAGENTS USED IN BIOTECHNOLOGY
- Table 27 AVERAGE PRICES OF CLASSICAL MEDIA, THROUGH 2006 ($/L)
- Table 28 AVERAGE PRICES OF SERA, THROUGH 2006 ($/L)
- Table 29 NEW PRODUCTS BY SIGMA-ALDRICH
- Table 30 NEW PRODUCTS BY IRVINE SCIENTIFIC
- Table 31 NEW PRODUCTS BY INVITROGEN CORPORATION
- Table 32 NEW PRODUCTS BY HYCLONE
- Table 33 NEW PRODUCTS BY ROCHE APPLIED SCIENCES
- Table 34 U.S. MARKET FORECAST FOR SALES OF MEDIA (SERUM FREE AND SERUM REQUIRING), THROUGH 2011 ($ MILLIONS)
- Table 35 U.S. MARKET FORECAST FOR SALES OF MEDIA (LIQUID AND POWDER), THROUGH 2011 ($ MILLIONS)
- Table 36 U.S. MARKET FORECAST FOR SALES OF MEDIA (CLASSICAL AND SPECIALTY), THROUGH 2011 ($ MILLIONS)
- Table 37 U.S. MARKET FORECAST FOR SALES OF SERA, THROUGH 2011 ($ MILLIONS)
- Table 38 U.S. MARKET FORECAST FOR BOVINE SERA, THROUGH 2011 ($ MILLIONS)
- Table 39 U.S. MARKET FORECAST FOR REAGENTS USED IN BIOTECHNOLOGY, THROUGH 2011 ($ MILLIONS)
- Table 40 U.S. MARKET FORECAST FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2011 ($ MILLIONS)
- Table 41 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2003-2006
- Table 42 PRODUCT-RELATED PATENT BREAKDOWN, 2003-2006
- Table 43 SIGNIFICANT PATENTS FOR MEDIA IN 2006
- Table 44 SIGNIFICANT PATENTS FOR SERA IN 2006
- Table 45 SIGNIFICANT PATENTS FOR REAGENTS IN 2006
- Table 46 PATENTS BY COMPANY, 2003-2006
- Table 47 SHARES OF PATENTS ISSUED BY EMPHASIS, 2003-2006
- Table 48 U.S. PATENTS BY COUNTRY AWARDED, 2003-2006
- Table 49 TRENDS OF PATENTS ISSUED BY COUNTRY, 2003-2006
- Table 50 SHARES OF U.S. PATENTS BY ASSIGNEE
- Table 51 U.S. EXPENDITURES OF MEDIA, SERA AND REAGENTS IN RESEARCH SEGMENT, THROUGH 2011 ($ MILLIONS)
- Table 52 U.S. MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN PRODUCTION SEGMENT, THROUGH 2011 ($ MILLIONS)
- Table 53 U.S. MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN CONTRACT SEGMENT, THROUGH 2011 ($ MILLIONS)
- Table 54 U.S. MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN OTHER SEGMENTS, THROUGH 2011 ($ MILLIONS)
- Table 55 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN LATIN AMERICA, THROUGH 2011 ($ MILLIONS)
- Table 56 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN EUROPE, THROUGH 2011 ($ MILLIONS)
- Table 57 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN ASIA, THROUGH 2011 ($ MILLIONS)
- Table 58 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN CANADA, THROUGH 2011 ($ MILLIONS)
- Table 59 MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN OTHER COUNTRIES, THROUGH 2011 ($ MILLIONS)
- Table 60 GLOBAL MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, THROUGH 2011 ($ MILLIONS)
- Table 61 GLOBAL MARKET SEGMENT OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, 2006 (%)
LIST OF FIGURES
- Summary Figure:
- U.S. SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, 2004-2011 ($ MILLIONS)
- Figure 1 ESTIMATED MARKET SHARE FOR SUPPLIERS AND MANUFACTURERS OF MEDIA, 2006 (%)
- Figure 2 ESTIMATED MARKET SHARE IN 2006 FOR SUPPLIERS AND MANUFACTURERS OF SERA (%)
- Figure 3 AVERAGE PRICES OF CLASSICAL MEDIA, 2003 AND 2006 ($/L)
- Figure 4 AVERAGE PRICES OF SERA, 2003 AND 2006 ($/L)
- Figure 5 SALES OF MEDIA (SERUM-FREE AND SERUM REQUIRING) IN U.S. ($ MILLIONS)
- Figure 6 SALES OF MEDIA (LIQUID AND POWDER) IN U.S. ($ MILLIONS)
- Figure 7 SALES OF MEDIA (CLASSICAL AND SPECIALTY) IN U.S. ($ MILLIONS)
- Figure 8 SALES OF SERA IN THE U.S. 2004-2011 ($ MILLIONS)
- Figure 9 SALES OF BOVINE SERA IN THE U.S., 2004-2011 ($ MILLIONS)
- Figure 10 U.S. SALES OF REAGENTS USED IN BIOTECHNOLOGY, 2004-2011 ($ MILLIONS)
- Figure 11 SALES OF BIOLOGICAL RESPONSE MODIFIERS IN THE U.S., 2004-2011 ($ MILLIONS)
- Figure 12 NUMBER OF PATENTS BY YEAR, 2003-2006
- Figure 13 PRODUCT-RELATED PATENT BREAKDOWN, 2003-2006 (%)
- Figure 14 SHARES OF PATENTS ISSUED BY EMPHASIS, 2003-2006 (%)
- Figure 15 NUMBER OF U.S. PATENTS BY ASSIGNEE
- Figure 16 SHARES OF U.S PATENTS BY ASSGINEE (%)
- Figure 17 U.S. EXPENDITURE OF MEDIA, SERA AND REAGENTS IN RESEARCH SEGMENT, 2004-2011 ($ MILLIONS)
- Figure 18 U.S. SALES OF MEDIA, SERA AND REAGENTS IN PRODUCTION SEGMENT, 2004-2011 ($ MILLIONS)
- Figure 19 U.S. SALES OF MEDIA, SERA AND REAGENTS IN CONTRACT SEGMENT, 2004-2011 ($ MILLIONS)
- Figure 20 U.S. SALES OF MEDIA, SERA AND REAGENTS IN OTHER SEGMENTS ($ MILLIONS)
- Figure 21 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN LATIN AMERICA, ($ MILLIONS)
- Figure 22 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN EUROPE, 2004-2011 ($ MILLIONS)
- Figure 23 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN ASIA, 2004-2011 ($ MILLIONS)
- Figure 24 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN CANADA, 2004-2011 ($ MILLIONS)
- Figure 25 SALES OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY IN OTHER COUNTRIES, THROUGH 2011 ($ MILLIONS)
- Figure 26 GLOBAL MARKET FORECAST FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, 2004-2011 ($ MILLIONS)
- Figure 27 WORLWIDE MARKET SEGMENT OF MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY, 2006 (%)

The Dynamic Media, Sera and Reagent Market in Biotechnology

Table of Contents